OC
CFMS

Oppenheimer & Co’s Conformis, Inc. Common Stock CFMS Stock Holding History

Oppenheimer & Co’s Portfolio CFMS Stock Details CFMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,949
Closed -$19K – 1458
2022
Q3 		$19K Sell
3,949
-334
-8% -$2.32K ﹤0.01% 1347
2022
Q2 		$38K Buy
4,283
+62
+1% +$708 ﹤0.01% 1372
2022
Q1 		$66K Sell
4,221
-272
-6% -$4.47K ﹤0.01% 1429
2021
Q4 		$86K Buy
4,493
+1,683
+60% +$43.1K ﹤0.01% 1452
2021
Q3 		$93K Sell
2,810
-1,600
-36% -$56.4K ﹤0.01% 1454
2021
Q2 		$127K Buy
4,410
+622
+16% +$14.7K ﹤0.01% 1460
2021
Q1 		$94K Buy
+3,788
New +$102K ﹤0.01% 1403
2018
Q4 		– Sell
-1,459
Closed -$39K – 1385
2018
Q3 		$39K Sell
1,459
-191
-12% -$5.19K ﹤0.01% 1330
2018
Q2 		$52K Buy
+1,650
New +$57K ﹤0.01% 1303

Other funds holding CFMS

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AWE
Avidian Wealth Enterprises Houston, Texas $3.16B AUM 20.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Oppenheimer & Co's CFMS Position: Q4 2022 in Review

Oppenheimer & Co sold out of Conformis, Inc. Common Stock (CFMS) in Q4 2022, closing a stake of 3,949 shares — an estimated $19K sold.

Oppenheimer & Co first reported a position in CFMS in Q2 2018 and held it in 9 quarters. The position peaked at $127K in Q2 2021. 35 funds tracked by Wall St. Rank hold CFMS as of Q4 2022.

  • Oppenheimer & Co reported no remaining Conformis, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Oppenheimer & Co sold 3,949 Conformis, Inc. Common Stock shares in Q4 2022, an estimated $19K.
  • Oppenheimer & Co first reported a position in Conformis, Inc. Common Stock in Q2 2018 and held it in 9 quarters.
  • Oppenheimer & Co's Conformis, Inc. Common Stock position peaked at $127K in Q2 2021.
  • 35 funds tracked by Wall St. Rank held Conformis, Inc. Common Stock as of Q4 2022.

Based on Oppenheimer & Co's 13F filing for Q4 2022, filed 8 Feb 2023.